| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tenaya Therapeutics, Inc. | Director | Stock Option (Right to buy) | 107,400 | 29 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TNYA | Tenaya Therapeutics, Inc. | 29 May 2025 | 1 | $0 | 4 | Director | 30 May 2025, 18:50 |
| TNYA | Tenaya Therapeutics, Inc. | 18 Oct 2024 | 1 | $0 | 4 | Director | 21 Oct 2024, 20:40 |
| TNYA | Tenaya Therapeutics, Inc. | 09 Jun 2023 | 1 | $0 | 4 | Director | 12 Jun 2023, 20:30 |
| TNYA | Tenaya Therapeutics, Inc. | 21 Nov 2022 | 1 | +$599,999 | 4 | Director | 09 Dec 2022, 18:59 |
| TNYA | Tenaya Therapeutics, Inc. | 10 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 20:58 |
| TNYA | Tenaya Therapeutics, Inc. | 29 Jul 2021 | 0 | $0 | 3 | Director | 29 Jul 2021, 19:52 |